19-year delay of Huntington’s disease diagnosis. A case study Case report
Article Sidebar
Main Article Content
Abstract
Huntington’s disease (HD) is a genetically determined (autosomal, dominant) neurodegenerative disease. There is no specific treatment of HD. The article describes a case of 59-year-old woman hospitalized for the first time in a psychiatric department, after 19 years from the onset and 3 years after neurologists diagnosed HD. At the time of hospitalization, the patient was psychotic and completely reliant on social assistance. The patient was administered haloperidol to give relief of psychotic symptoms, reducing suicidal thoughts and chorea movements.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Rowland LP. Neurologia Merritta. Wrocław 2004: 659-662.
3. Bradley WG, Daroff RB, Fenichel GM, Jankovic J. Neurologia w praktyce klinicznej. Lublin 2006: 2569-2574.
4. Pużyński S, Rybakowski J, Wciórka J. Psychiatria. Psychiatria Kliniczna. Elsevier, Wrocław 2011: 68-69.
5. Rudzińska M. Komentarz do wytycznych dotyczących farmakologicznego leczenia pląsawicy Huntingtona. Online: www.mp.pl/artykuly80783.
6. Charvin D, Roze E, Perrin V et al. Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiol Dis 2008; 29(1): 22-29.